Susquehanna International Group’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Buy
264,900
+76,600
+41% +$463K ﹤0.01% 6738
2025
Q4
$987K Buy
188,300
+93,300
+98% +$369K ﹤0.01% 7221
2025
Q3
$411K Buy
+95,000
New +$171K ﹤0.01% 9416
2025
Q1
Sell
-12,100
Closed -$30.3K 13604
2024
Q4
$30.3K Sell
12,100
-113,400
-90% -$404K ﹤0.01% 11836
2024
Q3
$510K Buy
+125,500
New +$469K ﹤0.01% 8422

Other funds holding ZURA

Susquehanna International Group's ZURA Position: Q1 2026 in Review

Susquehanna International Group reduced its Zura Bio (ZURA) stake by 83% in Q1 2026, selling an estimated $1.43M and leaving 47,886 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #10974.

Susquehanna International Group first reported a position in ZURA in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.49M in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Susquehanna International Group held 47,886 shares of Zura Bio worth $285K as of Q1 2026.
  • Susquehanna International Group sold 236,211 Zura Bio shares in Q1 2026, an estimated $1.43M.
  • Zura Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10974 holding.
  • Susquehanna International Group first reported a position in Zura Bio in Q4 2023 and has held it in 8 quarters since.
  • Susquehanna International Group's Zura Bio position peaked at $1.49M in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.